ANORECTIC EFFECT AND BRAIN CONCENTRATIONS OF D-FENFLURAMINE IN THE MARMOSET - RELATIONSHIP TO THE INVIVO AND INVITRO EFFECTS ON SEROTONERGIC MECHANISMS

被引:14
作者
CACCIA, S
ANELLI, M
FRACASSO, C
FRITTOLI, E
GIORCELLI, P
GOBBI, M
TADDEI, C
GARATTINI, S
MENNINI, T
机构
[1] Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, I-20157
关键词
D-FENFLURAMINE; D-NORFENFLURAMINE; MARMOSET; ANORECTIC-ED(50); EFFECTS ON SEROTONINERGIC MECHANISMS;
D O I
10.1007/BF00167450
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigated the anorectic activity of d-fenfluramine (d-F) and the relationship with brain levels of unchanged drug and its metabolite d-norfenfluramine (d-NF) in marmosets, relating them to neurochemical effects on the serotoninergic system. d-F and d-NF were equally active in reducing food intake (ED50 about 3 mg/kg, p.o.). However, the brain concentrations of the metabolite required to reduce food intake after synthetic d-NF were more than twice those after d-F, indicating that d-NF contributes to but does not completely explain the anorectic effect of d-F. At this dose d-F did not appreciably modify the serotonin (5-HT) and 5-hydroxyindoleacetic (5-HIAA) contents of the brain regions examined, except for a slight enhancement of 5-HIAA in hippocampus. In vitro in brain cortical synaptosomes d-F inhibited [H-3]5-HT uptake more potently than d-NF, as in other species. d-F and d-NF showed similar potency in stimulating [H-3]5-HT release, in a Ca++ dependent manner. The tritium released by d-F and d-NF appeared to be mainly unmetabolized [H-3]5-HT. Like in other species the marmoset too has saturable and specific [H-3]d-F binding sites, for which d-NF has lower affinity. d-F and d-NF have low affinities for 5-HT receptor subtypes, except that d-NF has appreciable affinity for 5-HT1C and 5-HT1D receptors. Unlike in rodents but similarly to primates in the striatum the pharmacology of 5-HT receptors seems to correspond to the 5-HT1D subtype. Brain concentrations of d-F and d-NF at anorectic doses exceeded the concentrations required in vitro to influence the serotoninergic system. Therefore the effect of d-F on food intake might possibly be explained by an interaction with the 5-HT system, particularly uptake and release mechanisms, and that of d-NF by an action on 5-HT1C and 5-HT1D receptor subtypes.
引用
收藏
页码:306 / 312
页数:7
相关论文
共 31 条
  • [11] BIOCHEMICAL PHARMACOLOGY OF THE ANORECTIC DRUG FENFLURAMINE - REVIEW
    GARATTINI, S
    CACCIA, S
    MENNINI, T
    SAMANIN, R
    CONSOLO, S
    LADINSKY, H
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 : 15 - 27
  • [12] GARATTINI S, 1987, BODY WEIGHT CONTROL, P261
  • [13] BINDING OF PHENYLALKYLAMINE DERIVATIVES AT 5-HT1C AND 5-HT2 SEROTONIN RECEPTORS - EVIDENCE FOR A LACK OF SELECTIVITY
    GLENNON, RA
    RAGHUPATHI, R
    BARTYZEL, P
    TEITLER, M
    LEONHARDT, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) : 734 - 740
  • [14] INVIVO (+)-[H-3]FENFLURAMINE BINDING TO RAT-BRAIN - BIOCHEMICAL AND AUTORADIOGRAPHIC STUDIES
    GOBBI, M
    TADDEI, C
    MENNINI, T
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (04) : 253 - 256
  • [15] DIFFERENT COMPONENTS OF H-3-IMIPRAMINE BINDING IN RAT-BRAIN MEMBRANES - RELATION TO SEROTONIN UPTAKE SITES
    GOBBI, M
    TADDEI, C
    MENNINI, T
    [J]. LIFE SCIENCES, 1988, 42 (05) : 575 - 583
  • [16] GOBBI M, 1992, N-S ARCH PHARMACOL, V345, P1
  • [17] THE DISTRIBUTION OF 5-HT3 RECOGNITION SITES IN THE MARMOSET BRAIN
    JONES, DNC
    BARNES, NM
    COSTALL, B
    DOMENEY, AM
    KILPATRICK, GJ
    NAYLOR, RJ
    TYERS, MB
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (01) : 63 - 67
  • [18] SPECIES-DIFFERENCES IN PRESYNAPTIC SEROTONIN AUTORECEPTORS - MAINLY 5-HT1B BUT POSSIBLY IN ADDITION 5-HT1D IN THE RAT, 5-HT1D IN THE RABBIT AND GUINEA-PIG BRAIN CORTEX
    LIMBERGER, N
    DEICHER, R
    STARKE, K
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1991, 343 (04) : 353 - 364
  • [19] CARRIER-MEDIATED AND CARRIER-INDEPENDENT RELEASE OF SEROTONIN FROM ISOLATED CENTRAL NERVE-ENDINGS
    MAURA, G
    GEMIGNANI, A
    VERSACE, P
    MARTIRE, M
    RAITERI, M
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1982, 4 (04) : 219 - 224
  • [20] DEXFENFLURAMINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN OBESITY
    MCTAVISH, D
    HEEL, RC
    [J]. DRUGS, 1992, 43 (05) : 713 - 733